'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney
Nestled in the high-tech Silicon Valley area, Doximity has positioned itself as a state-of-the-art, social-media-driven community, but one dedicated exclusively to physicians. The company has announced that its signed-on membership among physicians is now over 400,000, representing roughly half of all prescribing physicians in the US and a quadrupuling since early 2013. In the intense battle for attention and interaction with physicians, in which pharma companies touting their products compete with healthcare providers, professional and personal interests and all the other things that physicians can look at on their computer screens or smartphones, the company is claiming a proprietary position, and doesn’t mind the informal association as the “LinkedIn of physicians,” according to Jeff Tangney, CEO.
However, unlike other physician-oriented online communities, Doximity neither accepts promotional dollars from pharma companies, nor integrates with vendors of drug-data services, marketing organizations or electronic health records (EHR) systems. In fact, the company sees itself at somewhat cross-purposes with EHR vendors. “It’s not just interoperability among EHR systems that’s the problem for that technology,” says Tangney, “it’s that the hospital systems that install them basically don’t want physicians communicating with each other outside the walls of their system. We represent a ‘back channel’ that allows physicians to communicate with each other.”
One distinction of Doximity is that it requires a fairly rigorous vetting process to ensure the credentials of subscribers; only appropriately licensed healthcare providers are allowed in. Another is that communications are not anonymous—physicians know who is communicating with them, unlike chat rooms where unknown persons try to connect with each other. And the communications can be rapid: Tangney cites a case where a physician, confronting with a pediatric patient in a seizure, needed to know quickly what meds the patient was taking. Nominally, an EHR system could provide that info (if both the physician and the patient’s healthcare provider were on the system), but that avenue wasn’t available. A quick communication to the provider generated the needed information for a potentially life-saving situation.
Without a subscription cost, healthcare provider support or an advertising platform (the usual means for social media sites to generate revenue), how will Doximity thrive? Tangney says that it has already located one valuable revenue stream: physician recruitment, a process that can cost tens of thousands of dollars for an employer to pay to locate and hire the right physician. Doximity has relationships with the recruiting offices of 300 hospital systems, says Tangney, and the business is growing nicely. Will there be a place for the pharma industry to interact with this community? “Stay tuned,” he says. The company is piloting several programs, including one for clinical trial site recruitment, and another for characterizing key opinion leader networks. But the priority for now will remain becoming an essential communication tool for physicians.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.